QIFENG
873169
KSEC Intelligent Technology
301311
Guangdong Topstar Technology
300607
4
Hengerda New Materials
300946
5
Aerospace Nanhu Electronic Information Technology
688552
US Stock MarketDetailed Quotes
BLFS BioLife Solutions
- 23.290
- +0.930+4.16%
Close May 9 16:00 ET
- 23.290
- 0.0000.00%
Post 20:01 ET
1.11BMarket Cap-101.26P/E (TTM)
25.240High21.410Low1.16MVolume21.410Open22.360Pre Close27.83MTurnover3.15%Turnover RatioLossP/E (Static)47.56MShares29.54552wk High3.14P/B859.16MFloat Cap18.70052wk Low--Dividend TTM36.89MShs Float72.188Historical High--Div YieldTTM17.13%Amplitude0.140Historical Low23.956Avg Price1Lot Size
BioLife Solutions News
Lake Street Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $30
Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Buy Rating, Announces Target Price $32
TD Cowen Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $31
BioLife Solutions: Strong Financial Performance and Strategic Positioning Justify Buy Rating
Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Buy Rating
Lake Street Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $30
Lake Street Sticks to Their Buy Rating for BioLife Solutions (BLFS)
KeyBanc Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $33
BioLife Solutions Price Target Raised to $30.00/Share From $27.00 by HC Wainwright & Co.
BioLife Solutions Is Maintained at Buy by HC Wainwright & Co.
BioLife Solutions Analyst Ratings
Maxim Group Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $34
H.C. Wainwright Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $30
Lake Street Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $30
Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Buy Rating, Announces Target Price $32
Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), BioLife Solutions (BLFS) and Surgery Partners (SGRY)
Benchmark Co. Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $30
TD Cowen Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $31
BioLife Solutions: Promising Financial Outlook and Strategic Positioning Justify Buy Rating
Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Buy Rating
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call